Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $112

Hinge Health, Inc. Class A

Hinge Health, Inc. Class A

HNGE

0.00

Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE: HNGE) with a Buy and raises the price target from $85 to $112.